These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin. Reid CL; Wiener GJ; Cox DW; Richter JE; Geisinger KR Gastroenterology; 1987 Jul; 93(1):181-7. PubMed ID: 3034714 [TBL] [Abstract][Full Text] [Related]
4. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria. Olusi SO Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465 [TBL] [Abstract][Full Text] [Related]
5. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W Ann Intern Med; 1992 Oct; 117(8):641-5. PubMed ID: 1530195 [TBL] [Abstract][Full Text] [Related]
6. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma? Charlionet R; Martin JP; Sesboué R; Ropartz C Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146 [No Abstract] [Full Text] [Related]
7. Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease. Bell H; Schrumpf E; Fagerhol MK Scand J Gastroenterol; 1990 Aug; 25(8):788-92. PubMed ID: 2402584 [TBL] [Abstract][Full Text] [Related]
10. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055 [TBL] [Abstract][Full Text] [Related]
11. Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis. Elzouki AN; Hultcrantz R; Stål P; Befrits R; Eriksson S Gut; 1995 Jun; 36(6):922-6. PubMed ID: 7615285 [TBL] [Abstract][Full Text] [Related]
12. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096 [TBL] [Abstract][Full Text] [Related]
14. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing. Vergalla J; Jones EA; Kew MC S Afr Med J; 1983 Dec; 64(24):950-1. PubMed ID: 6316569 [TBL] [Abstract][Full Text] [Related]
15. Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. Eriksson S; Moestrup T; Hägerstrand I Acta Med Scand; 1975 Oct; 198(4):243-7. PubMed ID: 171917 [TBL] [Abstract][Full Text] [Related]
16. An association between alpha 1-antitrypsin phenotype and chronic liver disease. Kishimoto Y; Yamada S; Hirayama C Hum Genet; 1990 Jan; 84(2):132-6. PubMed ID: 2153626 [TBL] [Abstract][Full Text] [Related]
17. Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Kelly JK; Davies JS; Jones AW J Clin Pathol; 1979 Apr; 32(4):373-6. PubMed ID: 221549 [TBL] [Abstract][Full Text] [Related]
18. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. Sveger T N Engl J Med; 1976 Jun; 294(24):1316-21. PubMed ID: 1083485 [TBL] [Abstract][Full Text] [Related]